Genomics is one of the most exciting emerging fields in medicine. It studies how our DNA interacts and impacts on our body and health. Clinical genomics investigates how an individual’s biological information can be used to improve their medical care and health outcomes through more effective diagnosis and personalised treatment.

Funding the future of Genomics

Our vision at St Vincent’s is to make genomic medicine accessible to everyone, with the goal of using genomics to tailor treatment for both common and rare diseases. To achieve this, more evidence is needed via translational research before genomics can be applied in routine patient care.

The Foundation is currently supporting development in this area by raising funds for a number of translational research projects ​undertaken at Clinical Genomics including:

  • Genetic causes of diabetes: This project investigates the use of ​genomic testing to ​identify inherited forms of the disease in order to improve health outcomes ​in patients with inherited diabetes, and their families.
  • Mental health pharmacogenomics: This body of work investigates the use of genomic testing to guide the choice and dose of medications (termed ‘pharmacogenomics’) to improve treatment outcomes in patients with anxiety, depression, and psychotic illnesses.
  • Australia’s first Randomised Controlled Trial (RCT): ​St Vincent’s Clinical Genomics is leading the first Australian double-blinded RCT into mental health pharmacogenomics. The ultimate goals are to use genomics to improve treatment outcomes of patients with Major Depression by enhancing treatment precision; and to increase genomic equity by lobbying for Medicare rebate for pharmacogenomic testing.

Donate today and help us to develop the medical advances of tomorrow.

More about Clinical Genomics Services at St Vincent’s

St Vincent’s provides an integrated Clinical Genomics service on our Darlinghurst campus, offering a range of procedures for patients and families, including:

  • Diagnostic testing – to assist in diagnosis and management of diseases,
  • Predictive testing – to inform disease and reproductive risk management,
  • Pharmacogenomics testing – to enable personalised prescription and management of medication, enhancing therapeutic effectiveness and minimising medication side effects and adverse ​drug reactions .

Click here to find out more about Clinical Genomics at St Vincent’s Hospital.

Donate now